Therapy Areas: Vaccines
Genixus names new CCO and new executive vice president, global head of Intellectual Property
3 March 2021 -

Genixus, a United States-based pharmaceutical company, has named Seth Coombs as its new chief commercial officer and Don Anthony JD PhD as its new executive vice president, global head of Intellectual Property, it was reported on Tuesday.

Prior to joining Genixus, Coombs has served Novartis in roles of increasing responsibility across three divisions. He has held the position of vice president, Commercial Operations & Alliance Management at Novartis' Sandoz division. He has also served as vice president, Oncology and Injectable products for Sandoz US and held several senior roles within Novartis Vaccines and Diagnostics.

Dr Anthony is an attorney focused on intellectual property and commercial pharmaceutical law. He has held various roles of increasing responsibility at various pharmaceutical companies, which includes senior vice president of Intellectual Property at Mayne Pharma.

Login
Username:

Password: